| Characteristic | Complete vaccination against COVID-19* | Overall N = 6041 | p-value2 | |
| No N = 5491 | Yes N = 551 | |||
| Age (Year), median (IQR)3 | 54 (41 - 68) | 55 (44 - 65) | 54 (41 - 68) | 0.740 |
| Age classes (Year) |
|
|
| 0.824 |
| <20 | 6 (100.0) | 0 (0.0) | 6 |
|
| 20 - 39 | 111 (91.0) | 11 (9.0) | 122 |
|
| 40 - 59 | 202 (89.4) | 24 (10.6) | 226 |
|
| 60 - 79 | 190 (91.3) | 18 (8.7) | 208 |
|
| ≥80 | 40 (95.2) | 2 (4.8) | 42 |
|
| Sex |
|
|
| 0.007 |
| Female | 284 (94.0) | 18 (6.0) | 302 |
|
| Male | 265 (87.7) | 37 (12.3) | 302 |
|
| Nationality |
|
|
| 0.200 |
| Togolese | 522 (91.3) | 50 (8.7) | 572 |
|
| Other | 27 (84.4) | 5 (15.6) | 32 |
|
| Diabetes |
|
|
| 0.893 |
| No | 394 (91.0) | 39 (9.0) | 433 |
|
| Yes | 155 (90.6) | 16 (9.4) | 171 |
|
| High blood pressure |
|
|
| 0.061 |
| No | 331 (92.7) | 26 (7.3) | 357 |
|
| Yes | 218 (88.3) | 29 (11.7) | 247 |
|
| Asthma |
|
|
| 0.067 |
| No | 529 (91.4) | 50 (8.6) | 579 |
|
| Yes | 20 (80.0) | 5 (20.0) | 25 |
|
| HIV infection |
|
|
| 0.758 |
| No | 518 (90.7) | 53 (9.3) | 571 |
|
| Yes | 31 (93.9) | 2 (6.1) | 33 |
|
| Renal insufficiency |
|
|
| 0.070 |
| No | 541 (91.2) | 52 (8.8) | 595 |
|
| Yes | 8 (72.7) | 3 (27.3) | 11 |
|
| Cancer |
|
|
| 0.381 |
| No | 545 (91.0) | 54 (9.0) | 599 |
|
| Yes | 4 (80.0) | 1 (20.0) | 5 |
|
| Hemoglobinopathy |
|
|
| 0.229 |
| No | 541 (91.1) | 53 (8.9) | 594 |
|
| Yes | 8 (80.0) | 2 (20.0) | 10 |
|
| Obesity |
|
|
| 0.335 |
| No | 538 (91.0) | 53 (9.0) | 591 |
|
| Yes | 11 (84.6) | 2 (15.4) | 13 |
|